|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/28 | (2006.01) |
| A61K 31/28 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/00 | (2018.01) |
| (11) | Number of the document | 3720433 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18815624.4 |
| Date of filing the European patent application | 2018-12-04 | |
| (97) | Date of publication of the European application | 2020-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/083551 |
| Date | 2018-12-04 |
| (87) | Number | WO 2019/110619 |
| Date | 2019-06-13 |
| (30) | Number | Date | Country code |
| 201762594184 P | 2017-12-04 | US | |
| 201862646553 P | 2018-03-22 | US | |
| 201862655568 P | 2018-04-10 | US | |
| 201862669095 P | 2018-05-09 | US | |
| 201862741313 P | 2018-10-04 | US | |
| 201862750595 P | 2018-10-25 | US |
| (72) |
ALA, Aftab , SE
BJARTMAR, Carl , SE
WEISS, Karl-Heinz , SE
SCHILSKY, Michael , SE
ASKARI, Frederick , SE
CZLONKOWSKA, Anna , SE
FERENCI, Peter , SE
HEDERA, Peter , SE
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | BIS-CHOLINE TETRATHIOMOLYBDATE FOR TREATING WILSON DISEASE |
| BIS-CHOLINE TETRATHIOMOLYBDATE FOR TREATING WILSON DISEASE |